Haemorrhagic gastritis and bleeding following rofecoxib administration

Clin Exp Rheumatol. 2005 Sep-Oct;23(5):727-8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Aged
  • Anti-Ulcer Agents / therapeutic use
  • Cyclooxygenase Inhibitors / adverse effects*
  • Female
  • Gastritis / diagnosis
  • Gastritis / drug therapy
  • Gastritis / etiology*
  • Gastrointestinal Hemorrhage / drug therapy
  • Gastrointestinal Hemorrhage / etiology*
  • Gastroscopy
  • Humans
  • Lactones / adverse effects*
  • Lansoprazole
  • Omeprazole / analogs & derivatives
  • Omeprazole / therapeutic use
  • Osteoarthritis / drug therapy
  • Sulfones / adverse effects*
  • Treatment Outcome

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Cyclooxygenase Inhibitors
  • Lactones
  • Sulfones
  • Lansoprazole
  • rofecoxib
  • Omeprazole